83781-95-7

Usage

Uses

Used in Organic Synthesis:
2-(Bromomethyl)-1-chloro-3-methoxybenzene is used as a reagent and intermediate in the production of pharmaceuticals, agrochemicals, and other fine chemicals. Its unique functional groups allow for further chemical reactions and modifications, making it a valuable building block in the synthesis of various bioactive molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-(Bromomethyl)-1-chloro-3-methoxybenzene is used as a key intermediate for the synthesis of various drug molecules. Its presence in the molecular structure can impart specific biological activities and properties to the final drug product, contributing to its therapeutic effects.
Used in Agrochemical Industry:
2-(Bromomethyl)-1-chloro-3-methoxybenzene is also utilized in the agrochemical industry as a precursor for the synthesis of various agrochemicals, such as pesticides and herbicides. Its unique structure can provide specific modes of action and selectivity towards target pests, enhancing the effectiveness of these agrochemicals.

Upstream product

• 3260-88-6 1-chloro-3-methoxy-2-methylbenzene 
• 1038726-89-4 2-chloro-6-methoxyphenylmethanol 

Downstream Products

• 83781-50-4 (2-chloro-6-methoxybenzyl)dimethylamine 
• 170737-91-4 2-(2-chloro-6-methoxyphenyl)acetonitrile 
• 1253186-73-0 N-(1-{[2-chloro-6-(methyloxy)phenyl]methyl}-1H-pyrazol-3-yl)-2,6-difluorobenzamide 
• 1588424-12-7 C₁₆H₁₂Cl₂N₂O₂ 
• 1588424-11-6 C₁₇H₁₄Cl₂N₂O₂ 
• 1588424-10-5 C₁₇H₁₅Cl₂N₃O 
• 1588422-93-8 3-(2-chloro-6-hydroxyphenyl)-7-((5-(2-(diethylamino)ethoxy)pyridin-2-yl)amino)-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1588422-92-7 3-(2-chloro-6-methoxyphenyl)-7-((5-(2-(diethylamino)ethoxy)pyridin-2-yl)amino)-1-ethyl-1,6-naphthyridin-2(1H)-one 
• 1256557-65-9 2-{[(2-chloro-6-methoxyphenyl)methyl]sulfanyl}-6-methylpyrimidin-4-ol 
• 83781-49-1 <2-((trimethylsilyl)methyl)-6-methoxybenzyl>trimethylammonium iodide 
• 83781-46-8 <2-((trimethylsilyl)methyl)-6-methoxybenzyl>dimethylamine 
• 83781-71-9 2-carbomethoxy-5-methoxy-1,2,3,4-tetrahydronaphthalene 

Relevant academic research and scientific papers

DIFLUOROMETHYLENE COMPOUND

The present invention relates to a compound having an URAT1 inhibitory activity, and to an URAT1 inhibitor, a blood uric acid level-reducing agent and a pharmaceutical composition containing the compound. More specifically, the present invention relates to a compound represented by the formula (I): wherein R1 is -Q1-A1 or the like; R2 is a hydrogen atom, a halogen atom, a lower alkyl group or the like; W1, W2, W3 and W4 are each independently a nitrogen atom or a methine group optionally having substituents, or the like; X and Y are each a single bond, an oxygen atom or the like; Z is a hydroxyl group or COOR3 or the like.

MULTIPLE KINASE PATHWAY INHIBITORS

Kinase with inhibitory activity against kinases disposed in multiple signaling pathways and their therapeutic uses.

NITROGENATED FUSED RING DERIVATIVE, PHARMACEUTICAL COMPOSITION COMPRISING THE SAME, AND USE OF THE SAME FOR MEDICAL PURPOSES

[Purpose] The present invention provides compounds useful as agents for the prevention or treatment of a sex hormone-dependent disease or the like. [Solution] The present invention provides nitrogen-containing fused ring derivatives represented by the following general formula (I) which has a GnRH antagonistic activity, prodrugs, salts, pharmaceutical compositions containing the same, medicinal uses thereof and the like. In the formula (I), rings A and B are independently aryl or heteroaryl; RA and RB are independently halogen, cyano, alkyl, alkylsulfonyl, -OW1, -SW1, -COW2, -NW3W4, -SO2NW3W4, aryl, etc.; RC is H or alkyl; E is oxygen atom, etc.; U is single bond or alkylene; and X is Y, -CO-Y, -SO2-Y -S-(alkylene)-Y, -O-(alkylene)-Y, -SO2-(alkylene)-Y, etc.; Y is Z or amino, etc.; and Z is cycloalkyl, heterocycloalkyl, aryl, heteroaryl, etc.

METHYL SULFANYL PYRMIDMES USEFUL AS ANTIINFLAMMATORIES, ANALGESICS, AND ANTIEPILEPTICS

The present invention relates to pyrimidine derivatives of Formula (Ia) and (Ib) (including tautomers, isomers, prodrugs, and pharmaceutically acceptable salts thereof). Said compounds are useful in the treatment of pain (such as neuropathic pain), inflammation, and epilepsy (by acting as anticonvulsants). Methods of medical treatment making use of said compounds, as well as additional compounds of Formula (IIa) and (IIb), are also disclosed.

N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INHIBITORS

The present invention relates to amide compounds, processes for their preparation, pharmaceutical compositions containing these compounds and to their use in the treatment of disorders, conditions or disorders such as allergic disorders, inflammatory disorders and disorders of the immune system.

GUANIDINE COMPOUNDS, AND USE THEREOF AS BINDING PARTNERS FOR 5-HT5 RECEPTORS

The invention relates to guanidine compounds of general formula (I), corresponding enantiomeric, diastereomeric, and/or tautomeric forms thereof, and pharmaceutically acceptable salts thereof. The invention further relates to the use of guanidine compounds as binding partners for 5-HT5 receptors in order to treat diseases modulated by 5-HT5 receptor activity, especially treat neurodegenerative and neuropsychiatric disorders and the signs, symptoms, and malfunctions associated therewith.

Heterocyclic compounds

The inventive subject matter relates to compounds, pharmaceutical compositions, and kits containing a heterocyclic compound represented by the formula (I) wherein R is an alkyl group optionally having substituent(s) etc., X is an amino group optionally having substituent(s), Y1 and Y2 are nitrogen atoms etc., an isomer or solvate thereof or a pharmaceutically acceptable salt thereof as an active ingredient.

1-H-3-aryl-pyrrolidine-2, 4-dione derivatives as pest-control agents

The present invention relates to new 1-H-3-aryl-pyrrolidine-2,4-dione derivatives of the formula (I) in which A, B, G, X, Y and Z have the meanings given in the description, to processes for their preparation, and to intermediates therefor. The compounds